Trinity Gold Nutrition, 60 Capsule, 30 day Supply recall — FDA D-0042-2025
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.
Overview of recall records associated with Trinity Gold Nutrition, including dates, categories and classifications where available.
Classification mix: Class II: 1.
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.
This page summarizes recall records in which the official source identifies Trinity Gold Nutrition as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.